Passa al contenuto
Merck
  • Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.

Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.

European journal of medicinal chemistry (2009-05-05)
Elena Dreassi, Alessandra Tania Zizzari, Federico Falchi, Silvia Schenone, Annalisa Santucci, Giovanni Maga, Maurizio Botta
ABSTRACT

A library of 23 pyrazolo-pyrimidine compounds Src tyrosine kinase (TK) inhibitors, that reduced proliferation of a human osteogenic sarcoma cell line, was taken to investigate lack of correlation between inhibition of cellular viability (CV%) and enzymatic inhibition constants (K(i) Src). With the aim of understanding this behaviour, we focused on physico-chemical parameters which characterize partition coefficient and diffusion through membrane. Parallel artificial membrane permeability assay (PAMPA) has been frequently used for the evaluation of in vitro permeability of new chemical entities and, in this paper, a new approach for determining permeability of low soluble compounds was obtained. Goodness of PAMPA methodology was confirmed by logK(w) and computational approaches, by VolSurf, Cerius(2) and QikProp software programs. The results suggest that the lipophilicity and passive diffusion across the membranes do not significantly influence the activity of the compounds. This trend can be explained by a different target for some of the compounds in our set. In fact some compounds resulted also to be active toward Abl enzyme, another cytoplasmatic TK.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Caffeina, powder, ReagentPlus®
Sigma-Aldrich
Theophylline, anhydrous, ≥99%, powder
Sigma-Aldrich
Caffeina, anhydrous, 99%, FCC, FG
Sigma-Aldrich
Acetaminofene, BioXtra, ≥99.0%
Sigma-Aldrich
Carbamazepine, powder
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Sigma-Aldrich
Acetaminofene, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
Furosemide
Sigma-Aldrich
Acetaminofene, analytical standard
Sigma-Aldrich
Ketoprofen, ≥98% (TLC)
Supelco
Warfarin, PESTANAL®, analytical standard
Sigma-Aldrich
Caffeina, Sigma Reference Standard, vial of 250 mg
Supelco
Warfarin, analytical standard
Sigma-Aldrich
Caffeina, meets USP testing specifications, anhydrous
Supelco
Caffeine solution, analytical standard, 1.0 mg/mL in methanol
Supelco
Caffeina, traceable to primary standards (LGC)
Sigma-Aldrich
Caffeina, anhydrous, tested according to Ph. Eur.
Sigma-Aldrich
Caffeina, BioXtra
Sigma-Aldrich
Carbamazepine, meets USP testing specifications
Sigma-Aldrich
Ketoprofen, meets USP testing specifications